High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrow.

Santini, G; De Souza, C; Congiu, A M; Nati, S; Marino, G; Soracco, M; Sertoli, M R; Rubagotti, A; Spriano, M; Vassallo, F; Rossi, E; Vimercati, R; Piaggio, G; Figari, O; Benvenuto, F; Abate, M; Truini, M; Ravetti, J L; Ribizzi, I; Damasio, E

Santini, G; De Souza, C; Congiu, A M; Nati, S; Marino, G; Soracco, M; Sertoli, M R; Rubagotti, A; Spriano, M; Vassallo, F; Rossi, E; Vimercati, R; Piaggio, G; Figari, O; Benvenuto, F; Abate, M; Truini, M; Ravetti, J L; Ribizzi, I; Damasio, E.

Affiliation

Santini G; Department of Hematology, S. Martino Hospital, Genova, Italy. ginosantini@smartino.ge.it

Leuk Lymphoma ; 33(3-4): 321-30, 1999 Apr.

Article in En | MEDLINE | ID: mdl-10221512

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow / Lymphoma, Non-Hodgkin / Hematopoietic Stem Cell Transplantation / Antineoplastic Agents, Alkylating / Cyclophosphamide Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Leuk Lymphoma Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 1999 Document type: Article Affiliation country: Italia Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links